Skip to Content

Seven Must-Read Stories (Week ending September 12, 2015)

Another chance to catch the most interesting and important articles from the previous week on MIT Technology Review.
    1. Peter Thiel Backs Biotech “Unicorn” Fighting Cancer Stem Cells
      Are stem cells at the root of common cancers? A startup named Stemcentrx thinks so.
    2. Why NASA Wants Microsoft’s HoloLens in Space
      The rocket carrying two HoloLens headsets to the International Space Station blew up in June, and NASA is planning another launch.
    3. Meltdown-Proof Nuclear Reactors Get a Safety Check in Europe
      Researchers say they could build a prototype of a molten-salt reactor, a safer, cleaner option for nuclear power, in 10 years.
    4. Allegations of Dirty Tricks as Effort to “Rescue” Bitcoin Falters
      A debate over the future of Bitcoin seems to be getting ugly – some people say their computers are being attacked to suppress their preferred changes.
    5. AI Software Goes Up Against Fourth Graders on Science Tests
      Making AI software take real school exams might accelerate progress toward machines with common sense.
    6. Smart Mouthguard Monitors Your Saliva and Your Health
      Researchers demonstrate a wearable system for tracking chemicals in saliva that may correspond to fatigue and other health issues.
    7. How Machine Vision Is About to Change the Fashion World
      The way fashion shows influence street-chic outfits has long been debated. Now a machine vision system that can track how fashions spread through society is providing the first hard evidence.
    <

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.